T. Huizinga

101.7k total citations · 8 hit papers
1.1k papers, 49.4k citations indexed

About

T. Huizinga is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, T. Huizinga has authored 1.1k papers receiving a total of 49.4k indexed citations (citations by other indexed papers that have themselves been cited), including 731 papers in Rheumatology, 274 papers in Immunology and 234 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in T. Huizinga's work include Rheumatoid Arthritis Research and Therapies (549 papers), Systemic Lupus Erythematosus Research (355 papers) and Monoclonal and Polyclonal Antibodies Research (225 papers). T. Huizinga is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (549 papers), Systemic Lupus Erythematosus Research (355 papers) and Monoclonal and Polyclonal Antibodies Research (225 papers). T. Huizinga collaborates with scholars based in Netherlands, United States and United Kingdom. T. Huizinga's co-authors include René E. M. Toes, Annette H M van der Helm–van Mil, David L. Scott, Frederick Wolfe, M. Kloppenburg, Andreea Ioan‐Facsinay, Cornelia F Allaart, Leendert A. Trouw, Ferdinand C. Breedveld and Diane van der Woude and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

T. Huizinga

1.1k papers receiving 48.2k citations

Hit Papers

Rheumatoid arthritis 1997 2026 2006 2016 2010 2006 1999 1997 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rheumatoid arthritis
    2010 2.5k citations T. Huizinga et al. profile →
  2. Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
    2006 844 citations T. Huizinga, René E. M. Toes et al. profile →
  3. Cytokine gene polymorphism in human disease: on-line databases
    1999 708 citations T. Huizinga et al. profile →
  4. Genetic influence on cytokine production and fatal meningococcal disease
    1997 650 citations T. Huizinga et al. profile →
  5. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review
    2012 544 citations René E. M. Toes, T. Huizinga et al. profile →
  6. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
    2011 414 citations Rachel Knevel, Parawee Suwannalai et al. profile →
  7. An overview of autoantibodies in rheumatoid arthritis
    2020 273 citations T. Huizinga et al. profile →
  8. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
    2022 96 citations Pascal H P de Jong, T. Huizinga et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Huizinga Netherlands 113 28.4k 14.7k 8.5k 6.9k 6.6k 1.1k 49.4k
Lars Klareskog Sweden 109 22.1k 0.8× 13.8k 0.9× 8.0k 0.9× 5.1k 0.7× 6.1k 0.9× 657 42.3k
David Isenberg United Kingdom 102 27.9k 1.0× 22.8k 1.5× 11.6k 1.4× 4.5k 0.7× 6.0k 0.9× 969 45.8k
Yehuda Shoenfeld Israel 115 23.0k 0.8× 20.2k 1.4× 6.9k 0.8× 8.3k 1.2× 8.2k 1.2× 1.6k 63.1k
Peter E. Lipsky United States 107 13.8k 0.5× 23.2k 1.6× 6.7k 0.8× 4.6k 0.7× 8.4k 1.3× 661 46.7k
Paul Emery United Kingdom 123 45.9k 1.6× 18.2k 1.2× 6.8k 0.8× 17.3k 2.5× 5.8k 0.9× 1.0k 67.0k
Josef S Smolen Austria 89 25.5k 0.9× 10.1k 0.7× 3.6k 0.4× 9.6k 1.4× 3.2k 0.5× 509 35.4k
Frank C. Arnett United States 67 24.3k 0.9× 9.2k 0.6× 4.8k 0.6× 5.6k 0.8× 4.2k 0.6× 196 37.7k
Iain B. McInnes United Kingdom 112 24.4k 0.9× 25.5k 1.7× 2.9k 0.3× 10.3k 1.5× 12.2k 1.9× 738 58.4k
Marc Feldmann United Kingdom 114 15.6k 0.5× 23.9k 1.6× 7.4k 0.9× 5.5k 0.8× 11.3k 1.7× 556 53.8k
Georg Schett Germany 118 22.5k 0.8× 18.0k 1.2× 3.2k 0.4× 6.1k 0.9× 21.6k 3.3× 1.1k 59.6k

Countries citing papers authored by T. Huizinga

Since Specialization
Citations

This map shows the geographic impact of T. Huizinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Huizinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Huizinga more than expected).

Fields of papers citing papers by T. Huizinga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Huizinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Huizinga. The network helps show where T. Huizinga may publish in the future.

Co-authorship network of co-authors of T. Huizinga

This figure shows the co-authorship network connecting the top 25 collaborators of T. Huizinga. A scholar is included among the top collaborators of T. Huizinga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Huizinga. T. Huizinga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Damen, J, Hans Ulrich Scherer, René E. M. Toes, et al.. (2024). Multitiered Proteome Analysis Displays the Hyperpermeability of the Rheumatoid Synovial Compartment for Plasma Proteins. Molecular & Cellular Proteomics. 24(2). 100900–100900.
3.
Baudoin, Paul, et al.. (2024). Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies. Lara D. Veeken. 64(3). 1052–1059. 4 indexed citations
4.
Ciaffi, Jacopo, Liesbeth J J Beaart-van de Voorde, Maarten K. Ninaber, et al.. (2023). Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort. RMD Open. 9(2). e002971–e002971. 4 indexed citations
5.
Bergstra, Sytske Anne, et al.. (2023). The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis. Journal of Scleroderma and Related Disorders. 8(3). 192–202. 3 indexed citations
6.
Curtis, Jeffrey R., Cecilie Heegaard Brahe, Mikkel Østergaard, et al.. (2019). Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies. Current Medical Research and Opinion. 35(9). 1483–1493. 15 indexed citations
7.
Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations
8.
Moel, Emma C. de, Elisa A. Rozeman, Ellen Kapiteijn, et al.. (2018). Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors. Cancer Immunology Research. 7(1). 6–11. 129 indexed citations
9.
Vlieland, T. P. M. Vliet, et al.. (2014). Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.. PubMed. 32(6 Suppl 86). S–8. 11 indexed citations
10.
Bakker, P., Ronald van den Berg, F. van Gaalen, et al.. (2014). IMPACT OF REPEATING IMAGING OF THE SACROILIAC JOINTS OVER ONE YEAR ON THE CLASSIFICATION ACCORDING THE ASAS AXIAL SPA CRITERIA OF PATIENTS. Clinical and Experimental Rheumatology. 32(5). 787–787. 1 indexed citations
11.
Rooy, D. P. C. de, Alexandra Zhernakova, Roula Tsonaka, et al.. (2013). A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis. Annals of the Rheumatic Diseases. 73(6). 1163–1169. 47 indexed citations
12.
Behrens, Frank, Mikkel Østergaard, Румен Стоилов, et al.. (2012). First in Patient Study of Anti-GM-CSF Monoclonal Antibody (MOR103) in Active Rheumatoid Arthritis: Results of a Phase 1b/2a Randomized, Double-Blind, Placebo-Controlled Trial. Data Archiving and Networked Services (DANS). 64(12). 4171–4172. 9 indexed citations
13.
Fleischmann, R, et al.. (2012). Sarilumab, a Subcutaneously-Administered, Fully-Human Monoclonal Antibody Inhibitor of the IL-6 Receptor: Effects On Hemoglobin Levels in a Clinical Trial for the Treatment of Moderate-to-Severe Rheumatoid Arthritis. Data Archiving and Networked Services (DANS). 1 indexed citations
14.
Finckh, Axel, et al.. (2012). COMPARATIVE EFFICACY OF BIOLOGICS AS MONOTHERAPY AND IN COMBINATION WITH METHOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO CONVENTIONAL DMARDS: A NETWORK META-ANALYSIS. Lara D. Veeken. 52(10). 93–93. 1 indexed citations
15.
Suwannalai, Parawee, Lotte A van de Stadt, Helga Radner, et al.. (2011). Avidity maturation of ACPA in rheumatoid arthritis.. Data Archiving and Networked Services (DANS). 1 indexed citations
16.
Broek, Maries van den, Naomi B. Klarenbeek, Linda Dirven, et al.. (2011). Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the Rheumatic Diseases. 70(8). 1389–1394. 98 indexed citations
17.
Huizinga, T., Peter A. Nigrović, Eric Ruderman, & Hendrik Schulze‐Koops. (2011). Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation: Commentary. 9(2). 71–72. 1 indexed citations
18.
Huizinga, T., Peter A. Nigrović, Eric Ruderman, & Hendrik Schulze‐Koops. (2011). Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS): Commentary. 9(3). 1 indexed citations
19.
Huizinga, T. & Annette H M van der Helm–van Mil. (2007). Prediction and prevention of rheumatoid arthritis. Revista Colombiana de Reumatología. 14(2). 106–114. 2 indexed citations
20.
Oosterhout, M. van, Ingeborg M. Bajema, E. W. Nivine Levarht, et al.. (2007). Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid arthritis. Arthritis & Rheumatism. 58(1). 53–60. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Klareskog Breakdown of academic impact, for papers by David Isenberg Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Peter E. Lipsky Breakdown of academic impact, for papers by Paul Emery Breakdown of academic impact, for papers by Josef S Smolen Breakdown of academic impact, for papers by Frank C. Arnett Breakdown of academic impact, for papers by Iain B. McInnes Breakdown of academic impact, for papers by Marc Feldmann Breakdown of academic impact, for papers by Georg Schett
Rankless by CCL
2026